相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The emerging roles of CFIm25 (NUDT21/CPSF5) in human biology and disease
Chioniso Patience Masamha
WILEY INTERDISCIPLINARY REVIEWS-RNA (2023)
EZH2-mediated inhibition of KLF14 expression promotes HSCs activation and liver fibrosis by downregulating PPARγ
Zhipeng Du et al.
CELL PROLIFERATION (2021)
Molecular and cellular mechanisms of liver fibrosis and its regression
Tatiana Kisseleva et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
NUDT21 regulates circRNA cyclization and ceRNA crosstalk in hepatocellular carcinoma
Xiaojing Li et al.
ONCOGENE (2020)
Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation
Tingting Weng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
The role of KLF14 in multiple disease processes
Xiaoyan Chen et al.
BIOFACTORS (2020)
Partial loss of CFIm25 causes learning deficits and aberrant neuronal alternative polyadenylation
Callison E. Alcott et al.
ELIFE (2020)
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
Maurizio Parola et al.
MOLECULAR ASPECTS OF MEDICINE (2019)
Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients
Yuan Chu et al.
ONCOGENE (2019)
Cleavage factor 25 deregulation contributes to pulmonary fibrosis through alternative polyadenylation
Tingting Weng et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation
Jingjing Huang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Matrix metalloproteinase functions in hepatic injury and fibrosis
Martin Roderfeld
MATRIX BIOLOGY (2018)
Liver fibrosis: Direct antifibrotic agents and targeted therapies
Detlef Schuppan et al.
MATRIX BIOLOGY (2018)
Molecular Mechanisms for CFIm-Mediated Regulation of mRNA Alternative Polyadenylation
Yong Zhu et al.
MOLECULAR CELL (2018)
NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression
Sheng Tan et al.
ONCOGENE (2018)
CFIm25 inhibits hepatocellular carcinoma metastasis by suppressing the p38 and JNK/c-Jun signaling pathways
Yunwu Wang et al.
Oncotarget (2018)
Mechanisms of hepatic stellate cell activation
Takuma Tsuchida et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Hepatic stellate cells as key target in liver fibrosis
Takaaki Higashi et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Localization of RNAPII and 3′ end formation factor CstF subunits on C. elegans genes and operons
Alfonso Garrido-Lecca et al.
TRANSCRIPTION-AUSTIN (2016)
Cre-ativity in the liver: Transgenic approaches to targeting hepatic nonparenchymal cells
Stephen N. Greenhalgh et al.
HEPATOLOGY (2015)
Cytoglobin as a Marker of Hepatic Stellate Cell-derived Myofibroblasts
Norifumi Kawada
FRONTIERS IN PHYSIOLOGY (2015)
Regulation of an Inflammatory Disease Kruppel-Like Factors and Atherosclerosis
Mukesh K. Jain et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance
Tom Luedde et al.
GASTROENTEROLOGY (2014)
CFIm25 links alternative polyadenylation to glioblastoma tumour suppression
Chioniso P. Masamha et al.
NATURE (2014)
Reduced Hepatic Stellate Cell Expression of Kruppel-Like Factor 6 Tumor Suppressor Isoforms Amplifies Fibrosis During Acute and Chronic Rodent Liver Injury
Zahra Ghiassi-Nejad et al.
HEPATOLOGY (2013)
Hepatic stellate cells in liver development, regeneration, and cancer
Chunyue Yin et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial-stellate cell deactivation induced by statins
Giusi Marrone et al.
JOURNAL OF HEPATOLOGY (2013)
Human TREX component Thoc5 affects alternative polyadenylation site choice by recruiting mammalian cleavage factor I
Jun Katahira et al.
NUCLEIC ACIDS RESEARCH (2013)
Kruppel-like factors in cancer
Marie-Pier Tetreault et al.
NATURE REVIEWS CANCER (2013)
Drug targeting to the diseased liver
Klaas Poelstra et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Pathogenesis of Liver Fibrosis
Virginia Hernandez-Gea et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
MeCP2 Controls an Epigenetic Pathway That Promotes Myofibroblast Transdifferentiation and Fibrosis
Jelena Mann et al.
GASTROENTEROLOGY (2010)
Evidence that cleavage factor Im is a heterotetrameric protein complex controlling alternative polyadenylation
Sol Kim et al.
GENES TO CELLS (2010)
Mammalian Kruppel-Like Factors in Health and Diseases
Beth B. McConnell et al.
PHYSIOLOGICAL REVIEWS (2010)
Silencing of the Transforming Growth Factor-β (TGFβ) Receptor II by Kruppel-like Factor 14 Underscores the Importance of a Negative Feedback Mechanism in TGFβ Signaling
Mark J. Truty et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Molecular Architecture of the Human Pre-mRNA 3′ Processing Complex
Yongsheng Shi et al.
MOLECULAR CELL (2009)
Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver
Scott L. Friedman
PHYSIOLOGICAL REVIEWS (2008)
RNA polymerase II pauses and associates with pre-mRNA processing factors at both ends of genes
Kira Glover-Cutter et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
TLR4 enhances TGF-β signaling and hepatic fibrosis
Ekihiro Seki et al.
NATURE MEDICINE (2007)
Knock-down of 25 kDa subunit of cleavage factor Im in Hela cells alters alternative polyadenylation within 3′-UTRs
Tomohiro Kubo et al.
NUCLEIC ACIDS RESEARCH (2006)
Sp1-and Kruppel-like transcription factors
J Kaczynski et al.
GENOME BIOLOGY (2003)
Matrix as a modulator of hepatic fibrogenesis
D Schuppan et al.
SEMINARS IN LIVER DISEASE (2001)
History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells
A Geerts
SEMINARS IN LIVER DISEASE (2001)
The role of Smad3 in mediating mouse hepatic stellate cell activation
B Schnabl et al.
HEPATOLOGY (2001)
分享论文
